摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,7-二羟基香豆素-3-羧酸 | 84738-35-2

中文名称
6,7-二羟基香豆素-3-羧酸
中文别名
——
英文名称
6,7-dihydroxy-2-oxo-2H-1-benzopyran-3-carboxylic acid
英文别名
6,7-Dihydroxychromone-3-carboxylic acid;6,7-dihydroxy-2-oxo-2H-chromene-3-carboxylic acid;6,7-Dihydroxy-2-oxo-2H-chromen-3-carbonsaeure;6,7-Dihydroxycoumarin-3-carboxylic Acid;6,7-dihydroxy-2-oxochromene-3-carboxylic acid
6,7-二羟基香豆素-3-羧酸化学式
CAS
84738-35-2
化学式
C10H6O6
mdl
——
分子量
222.154
InChiKey
STCWBNGIVIFZHI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    270°C(dec.)(lit.)
  • 沸点:
    557.4±50.0 °C(Predicted)
  • 密度:
    1.788±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    104
  • 氢给体数:
    3
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    参考文献:
    名称:
    7-.alpha.-methoxycephalosporin derivatives, and antibacterial drugs
    摘要:
    小说7.alpha.-甲氧基头孢菌素衍生物,其药学上可接受的盐,其制备过程以及涉及该衍生物或盐的抗菌药物。该衍生物或盐对革兰氏阳性菌和革兰氏阴性菌有效。
    公开号:
    US04344944A1
  • 作为产物:
    描述:
    6,7-dihydroxy-2-oxo-2H-chromene-3-carboxylic acid ethyl ester 在 硫酸 作用下, 生成 6,7-二羟基香豆素-3-羧酸
    参考文献:
    名称:
    v. Pechmann; v. Krafft, Chemische Berichte, 1901, vol. 34, p. 423
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • ARYLOYL(OXY OR AMINO)PENTAFLUOROSULFANYLBENZENE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PRODRUGS THEREOF
    申请人:UBE INDUSTRIES, LTD.
    公开号:US20160244407A1
    公开(公告)日:2016-08-25
    An aryloyl(oxy or amino)pentafluorosulfanylbenzene compound having pharmacological action. The aryloyl(oxy or amino)pentafluorosulfanylbenzene compound is represented by general formula (A-I), a pharmaceutically acceptable salt thereof, and a prodrug thereof, wherein all of parameters represent the same meanings as defined in the specification.
    一种具有药理作用的芳基酰氧或基五磺基苯化合物。该芳基酰氧或基五磺基苯化合物由通用式(A-I)表示,其药用可接受的盐和前药,其中所有参数的含义与规范中定义的相同。
  • Cephalosporin compounds and antibacterial drugs containing the same
    申请人:Eisai Co., Ltd.
    公开号:US04285941A1
    公开(公告)日:1981-08-25
    Novel cephalosporin compounds of the general formula: ##STR1## wherein R.sub.1 represents a substituted or unsubstituted nitrogen-containing heterocyclic-thio group, R.sub.2 represents hydrogen or hydroxy, and R.sub.3, R.sub.4 and R.sub.5 each represents hydrogen, hydroxy or acyloxy, and their salts, and processes for the preparation thereof. The novel compounds and their salts have antibacterial activity.
    一种一般公式为:##STR1## 的新头孢菌素化合物,其中R.sub.1代表取代或未取代的含氮杂环基团,R.sub.2代表氢或羟基,R.sub.3、R.sub.4和R.sub.5分别代表氢、羟基或酰氧基,以及它们的盐,并且其制备方法。这些新化合物及其盐具有抗菌活性。
  • Coumarin derivatives with comt inhibiting activity
    申请人:——
    公开号:US20030186975A1
    公开(公告)日:2003-10-02
    Compounds of formula (I′) wherein the two OH— substituents in the phenyl moiety are in a position ortho to one another and R1 in a position ortho to one of the hydroxy groups; and X, R 1 to R 6 are as defined in claims, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.
    式(I')的化合物,其中苯基上的两个OH-取代基相对位于邻位,R1位于其中一个羟基的邻位;并且X,R1到R6如权利要求所定义的,表现出COMT酶抑制活性,因此它们可用作COMT抑制剂
  • Cephalosporin derivatives, and antibacterial drugs containing the
    申请人:Eisai Co., Ltd.
    公开号:US04285939A1
    公开(公告)日:1981-08-25
    New cephalosporin derivatives represented by the general formula: ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3 each represents hydroxy, acyloxy, and hydrogen provided that two or three of R.sub.1, R.sub.2, and R.sub.3 are not hydrogen at the same time, and their salts, and processes for the preparation thereof. The cephalosporin derivatives of the present invention are useful as antibacterial drugs.
    新的头孢菌素生物的一般式表示为:##STR1## 其中R.sub.1,R.sub.2和R.sub.3分别表示羟基,酰氧基和氢,条件是R.sub.1,R.sub.2和R.sub.3中的两个或三个同时不是氢,并且它们的盐以及制备它们的过程。本发明的头孢菌素生物可用作抗菌药物。
  • Cephalosporin compounds
    申请人:Eisai Co., Ltd.
    公开号:US04468394A1
    公开(公告)日:1984-08-28
    A compound represented by the formula: ##STR1## wherein R.sub.1 is hydrogen or methoxy; R.sub.2 is hydrogen or hydroxy; R is ##STR2## wherein R.sub.3 and R.sub.4 are hydroxy or acyloxy, Y is oxygen, sulfur or >N-R.sub.5 wherein R.sub.5 is hydrogen or lower alkyl, and Z is sulfur or >N-R.sub.5 wherein R.sub.5 has the same meanings as defined above; and X is ##STR3## wherein R.sub.6 is acyloxy or nitrogen-containing heterocyclicthio which may have substituent(s), a pharmaceutically accpetable salt thereof, and a carboxylic ester thereof. This compound has improved antibacterial activity against Kleb. pneumoniae and Pseud. aeruginosa.
    一种化合物的化学式为:##STR1##其中R.sub.1是氢或甲氧基;R.sub.2是氢或羟基;R是##STR2##其中R.sub.3和R.sub.4是羟基或酰氧基,Y是氧,或>N-R.sub.5,其中R.sub.5是氢或较低的烷基,Z是或>N-R.sub.5,其中R.sub.5具有上述定义的相同含义;X是##STR3##其中R.sub.6是酰氧基或含氮杂环基,可以具有取代基,其药学上可接受的盐和羧酸酯。该化合物对Kleb. pneumoniae和Pseud. aeruginosa具有改善的抗菌活性。
查看更多